Status and phase
Conditions
Treatments
About
This study will compare the pharmacokinetics and pharmacodynamics, after single subcutaneous application, in healthy men, between pegfilgrastim formulation, produced by Megalabs (test product) and Neulastim® (reference product) Amgen.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
72 participants in 2 patient groups
Loading...
Central trial contact
Victoria Rodríguez, MD; Marcos Giusti, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal